Skip to content

Country

Millipore Filter Microplate MultiScreen 96 Well Ultracel-PPB - Pack of 2 Plates

Availability:
3 in stock, ready to be shipped
SKU 6404
Save 70% Save 70%
Original price $100.00
Original price $100.00 - Original price $100.00
Original price $100.00
Current price $30.00
$30.00 - $30.00
Current price $30.00

Millipore MultiScreen Ultrafree-PPB Filter Plate – 96-Well, Plasma Protein Binding Assay, Ultracel Membrane

The Millipore MAPPB1002 is a highly specialized 96-well MultiScreen filter plate assembly engineered specifically for high-throughput Plasma Protein Binding (PPB) studies and drug candidate distribution profiling. Unlike traditional, time-consuming equilibrium dialysis setups, this automation-compatible platform features integrated Ultracel® regenerated cellulose membranes calibrated for rapid, centrifugal-based separation of free (unbound) drugs from protein-bound drug fractions in serum or plasma samples. Designed to handle a 500 µL maximum filter well headspace, the single-piece plate configuration exhibits exceptionally low non-specific drug adsorption, delivering the high-precision volumetric recoveries and consistent lot-to-lot reliability demanded by ADME/Tox screening workflows in preclinical drug discovery.

Technical Performance and Design

  • Ultracel® PPB Regenerated Cellulose Membrane: Formulated specifically to ensure ultra-low non-specific drug binding. This material ensures that test compounds pass cleanly through the filter barrier without sticking to the polymer, providing highly accurate concentration profiles of free versus bound therapeutics.

  • Centrifugal High-Throughput Alternative: Engineered to process up to 96 samples simultaneously via clinical or laboratory swinging-bucket centrifuges. This system drastically compresses the standard 24-to-48-hour timelines required by legacy dialysis methods down to a single spinning cycle.

  • Dual-Capacity Volumetric Configuration: Offers a maximum structural filter well capacity of 500 µL. When paired with standard 300 µL receiver microtiter plates, it safely handles a 300 µL working fluid volume, expandable up to 500 µL if matched with an external deepwell collection block.

  • Standardized Automation Footprint: Adheres strictly to universal ANSI/SLAS microplate dimensional criteria, guaranteeing seamless alignment with robotic fluid handlers, automated multichannel pipetting heads, and stacker transport grippers.

Product Specifications

  • Catalog Number / MPN: MAPPB1002

  • Product Family: MultiScreen® Ultracel-PPB

  • Format: 96-Well High-Throughput Centrifugal Filter Plate

  • Membrane Matrix: Ultracel® Regenerated Cellulose (Optimized for Protein Binding)

  • Filter Well Capacity: 500 µL Maximum

  • Working Sample Volume: 300 µL (Using standard included receiver plates)

  • Centrifugation Limits: 2,000 × g Recommended Operating Force (3,000 × g Maximum Limit)

  • Sterility: Non-Sterile

Key Benefits & Applications

  • Preclinical ADME / Tox Screening: The industry-baseline standard for determining the plasma protein binding affinity of chemical libraries, a crucial parameter for determining in vivo pharmacokinetic drug distribution and clearance rates.

  • Free-Drug Fraction Quantitation: Safely filters out dense serum albumin and alpha-1-acid glycoprotein complexes, leaving behind a clean, protein-free ultrafiltrate optimized for direct injection into downstream LC-MS/MS systems.

  • Assay Miniaturization: Minimizes the required volumes of costly test compounds, target proteins, and primary animal serum vectors, maximizing data generation per microgram of analyte.

  • Process Automation: Eliminates the tedious manual manipulation, loading, and tracking steps associated with multi-chamber dialyzer membranes, adapting flawlessly to automated liquid-handling workflows.


All product names, logos, and brands are property of their respective owners.

Please note that Life Sciences Trading is not a factory-authorized distributor of the products listed in this store. The items have been acquired as surplus from leading life sciences companies.